«

»

A Proposal to Import Drugs from Other Countries Creates an Unusual Alliance in the Senate

Harmony is not often found between two of the most boisterous senators on Capitol Hill, Bernie Sanders (I-Vt.) and Rand Paul (R-Ky.). But it was there at Tuesday’s Senate Health, Education, Labor and Pensions Committee markup of legislation to reauthorize the Food and Drug Administration’s user fee program, which is set to expire Sept. 30. This user fee program, which was first authorized in 1992, allows the FDA to collect fees from companies that submit applications for drug approval. It was designed to speed the approval review process. And it requires reauthorization every five years. Congress considers this bill a must-pass piece of legislation because ...

Read the full post at Syndicate – Kaiser Health News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive